Martingale Asset Management’s Immunovant IMVT Stock Holding History

Martingale Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$462K	Buy
2023 Q2	–	Sell
2023 Q1	$335K	Sell
2022 Q4	$705K	Sell
2022 Q3	$392K	Buy
2022 Q2	$274K	Buy
2022 Q1	$386K	Buy
2021 Q4	$527K	Buy
2021 Q3	$513K	Buy
2021 Q2	$207K	Buy